Updated:
IQ Capital
IQ Capital was founded in 2006 by Kerry Baldwin and Max Bautin, who spotted that the University of Cambridge's research output was generating world-class...
IQ Capital
IQ Capital was founded in 2006 by Kerry Baldwin and Max Bautin, who spotted that the University of Cambridge's research output was generating world-class deeptech startups with no dedicated local venture pool. They built a firm to capture that specific inefficiency—funding PhD founders in AI, quantum, cybersecurity, materials science and synthetic biology before those sectors registered on the radar of London's financial-district generalists. The firm now runs operations from both London and Cambridge, maintaining physical proximity to the laboratories and engineering departments that generate its pipeline. The firm invests from seed to growth across four fund generations, typically writing initial cheques of £1–10 million and reserving significant follow-on capacity to support companies through subsequent rounds. Its strategy spans AI/ML platforms, enterprise software, cybersecurity infrastructure, computational health, advanced materials and space technology. Publicly confirmed portfolio companies include Thought Machine (cloud-native banking infrastructure), Fluidic Analytics (biotechnology), Privitar (data privacy), Nyobolt (ultra-fast charging battery technology), Riverlane (quantum computing software) and Phlux Technology (infrared sensor hardware). IQ Capital has established itself as a named co-investor alongside funds like Balderton, Atomico and Index Ventures in rounds where deep technical due diligence is the difference between conviction and a pass. The geographic mandate concentrates on the UK and Northern Europe, with portfolio companies frequently scaling into US markets post-Series B. In July 2024 the firm closed IQ Capital Fund IV at $400 million, oversubscribed against a $350 million target, with commitments from British Patient Capital, the European Investment Fund and a roster of university endowments (per the firm, July 2024). This brought total capital raised across institutional funds to over $1 billion, cementing IQ Capital's position as one of the largest dedicated deeptech venture platforms in Europe. The partnership includes Simon Thorpe as Chairman—formerly a Managing Director at Investcorp's technology practice—and a specialist investment team drawn from operating backgrounds in engineering and academic research. Headcount is not publicly disclosed; the firm runs lean, consistent with early-stage specialist practice. The structural differentiator is IQ Capital's commitment to originating deals inside university departments rather than waiting for startups to emerge into visible accelerator cohorts. The firm employs dedicated scouts embedded within Cambridge's Maxwell Centre, Imperial College London's White City campus and Oxford's Begbroke Science Park—giving it first-look access to technology still confined to academic papers. This upstream sourcing model means IQ Capital frequently leads rounds before competitors have completed technical diligence. The firm also operates a growth-stage arm, IQ Capital Growth Fund, writing $15–30 million cheques for later-stage portfolio winners, effectively providing internal follow-on capital that reduces dependence on external growth investors.
General information
Firm type
Venture Capital
Year founded
2006
AUM
$600M - $1B (Altss estimate)
Location
Region
Europe
Country
United Kingdom
City
London
Corporate office
London, United Kingdom
Additional offices
Cambridge, United Kingdom
Principals
Kerry Baldwin
Managing Partner
Max Bautin
Managing Partner
Simon Thorpe
Chairman
Sector focus
Frequently asked questions
How does IQ Capital source proprietary deal flow?
IQ Capital maintains embedded relationships with university research departments, deploying scouts and advisors within the Maxwell Centre at Cambridge, Imperial College London and Oxford's Begbroke Science Park. This allows the firm to identify PhD-founded startups before they reach mainstream accelerators. The team performs technical due diligence directly on academic research, often leading pre-seed and seed rounds where competitors lack the engineering expertise to evaluate the technology credibly.
What distinguishes IQ Capital's investment strategy from a generalist European VC?
IQ Capital's partnership is staffed by former engineers and researchers who assess deals on technical merit first. Unlike generalist firms that rely on market-sizing exercises, IQ Capital evaluates molecular biology protocols, semiconductor architectures or quantum error-correction algorithms as part of routine diligence. This capability underpins an investment strategy concentrated entirely on deeptech sectors—AI/ML, quantum computing, cybersecurity, advanced materials, synthetic biology and space technology—where the founders hold PhDs or equivalent research credentials.
Does IQ Capital invest exclusively at seed stage?
No. While seed and Series A represent the firm's core activity, IQ Capital operates a dedicated growth-stage vehicle—IQ Capital Growth Fund—that writes $15–30 million cheques into later-stage portfolio companies. This internal follow-on structure allows the firm to retain significant ownership positions through Series C and beyond, reducing dilution from external growth investors. The combined platform covers pre-seed through late-stage expansion within the same deeptech mandate.
Who runs investment decisions at IQ Capital?
Day-to-day investment decisions are led by Managing Partners Kerry Baldwin and Max Bautin, who co-founded the firm in 2006. Simon Thorpe, former Managing Director at Investcorp Technology Partners, serves as Chairman and provides strategic oversight. The partnership operates a consensus-driven investment committee; specific voting structures and individual check-size authorities are not publicly disclosed.
Which sectors does IQ Capital explicitly avoid?
Based on its observed portfolio and published mandate, IQ Capital does not invest in consumer internet, e-commerce, digital media, hospitality or pure software-as-a-service plays without a defensible hard-science or engineering moat. The firm's capital is reserved for companies where intellectual property originates in university research or corporate R&D labs, effectively excluding business-model innovation plays that dominate generalist venture portfolios.
What is IQ Capital's typical check size and reserve strategy?
Initial cheques range from £1 million to £10 million at seed and Series A, with reserves allocated for multiple follow-on rounds. The firm's growth-stage vehicle provides additional firepower of $15–30 million for portfolio companies reaching commercial scale. This approach ensures portfolio companies retain access to insider capital across their full lifecycle, a structural advantage over seed-only funds that must syndicate growth rounds to external players.
How is IQ Capital related to the University of Cambridge?
IQ Capital is an independent private partnership with no legal or financial affiliation to the University of Cambridge. The commercial relationship is one of proximity and embedded scouting—the firm places personnel within Cambridge research centres to identify investment opportunities. Fund IV raised capital from institutional LPs including the European Investment Fund and British Patient Capital; none of the firm's limited partners include the University of Cambridge endowment.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on venture capital firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: